All Releases
| |
Peplin Announces the Initiation of Phase 3 Clinical Trials for PEP005 Gel in AK on the Face and Scalp
Jun 8, 2009
|
28.4 KB |
| |
Peplin's Successful Phase II AK Trial Results Published in JAAD
May 27, 2009
|
23.9 KB |
| |
Positive Results for Peplin's First Phase III AK Trial
May 17, 2009
|
42.3 KB |
| |
Results for quarter ended 31 March 2009
May 15, 2009
|
298.3 KB |
| |
Peplin's Positive Phase IIb AK Trial Result Details
Mar 5, 2009
|
78.9 KB |
| |
Peplin Results for the Quarter Ended 31 December 2008
Feb 13, 2009
|
29.6 KB |
| |
Positive Results for Peplin's Phase IIb AK Trial
Jan 8, 2009
|
31.1 KB |
| |
Peplin Completes Enrolment for its First Phase III AK Clinical Trial
Dec 16, 2008
|
22.5 KB |
| |
Results for Quarter ending 30 September 2008
Dec 1, 2008
|
31.4 KB |
| |
Peplin to present at the 2008 Rodman & Renshaw Healthcare Conference
Nov 10, 2008
|
22.5 KB |
| |
Registration statement declared effective
Nov 4, 2008
|
103.9 KB |
| |
Corporate Governance Statement
Nov 3, 2008
|
36.8 KB |
| |
Amendment two to Form 10 registration statement
Oct 28, 2008
|
1.3 MB |
| |
Peplin completes US$24m fundraising
Oct 24, 2008
|
24.9 KB |
| |
Amendment one to Form 10 registration statement
Oct 20, 2008
|
1.1 MB |
| |
Peplin's acquisition of Neosil complete
Oct 20, 2008
|
24.8 KB |
| |
Peplin to present at 2008 Wilson HTM Investment Group Life Science Conference
Oct 16, 2008
|
149.1 KB |
| |
Results of Annual General Meeting
Oct 6, 2008
|
19.2 KB |
| |
2008 Annual Meeting of Stockholders Script
Oct 6, 2008
|
753.4 KB |
| |
The dawn of a new era presentation
Sep 24, 2008
|
656.0 KB |
|
|
